Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

specific

A malignant small round cell tumor with or without neural differentiation that is resistant to treatment.

Centers

118

Active Trials

—

Cancer Funding

Top Centers for Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor(46)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
2	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
3	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
4	Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
5	Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
6	Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
7	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
8	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
9	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
10	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
11	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
12	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
13	University of Wisconsin Carbone Cancer CenterMadison, WI NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
14	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
15	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	3	—	56.5
16	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
17	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
18	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical Active Research Program	Active Research Program	3	—	56.5
19	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
20	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	3	—	56.5
21	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
22	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	3	—	56.5
23	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
24	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	3	—	56.5
25	Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program	Active Research Program	3	—	56.5
26	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	3	—	56.5
27	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	3	—	56.5
28	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	3	—	56.5
29	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	3	—	56.5
30	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	3	—	56.5
31	Livestrong Cancer InstitutesAustin, TX Active Research Program	Active Research Program	3	—	56.5
32	University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR Active Research Program	Active Research Program	3	—	56.5
33	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	3	—	56.5
34	Loma Linda University Cancer CenterLoma Linda, CA Active Research Program	Active Research Program	3	—	56.5
35	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	3	—	56.5
36	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	2	—	37.4
37	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	2	—	37.4
38	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	2	—	37.4
39	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	2	—	37.4
40	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Contributing Research Center	Contributing Research Center	1	—	33.0
41	Cedars-Sinai CancerLos Angeles, CA Contributing Research Center	Contributing Research Center	1	—	33.0
42	Boston University Cancer CenterBoston, MA Contributing Research Center	Contributing Research Center	1	—	33.0
43	Stony Brook Cancer CenterStony Brook, NY Contributing Research Center	Contributing Research Center	1	—	33.0
44	Tampa General Hospital Cancer InstituteTampa, FL Contributing Research Center	Contributing Research Center	1	—	33.0
45	Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive		—	—	29.6
46	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	29.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →